BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26068507)

  • 1. Cost-effectiveness of a repeat HIV test in pregnancy in India.
    Joshi S; Kulkarni V; Gangakhedkar R; Mahajan U; Sharma S; Shirole D; Chandhiok N
    BMJ Open; 2015 Jun; 5(6):e006718. PubMed ID: 26068507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic evaluation of HIV screening in pregnant women attending antenatal clinics in India.
    Kumar M; Birch S; Maturana A; Gafni A
    Health Policy; 2006 Jul; 77(2):233-43. PubMed ID: 16126300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal antenatal human immunodeficiency virus (HIV) testing programme is cost-effective despite a low HIV prevalence in Hong Kong.
    Lee PM; Wong KH
    Hong Kong Med J; 2007 Jun; 13(3):199-207. PubMed ID: 17548908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus retesting during pregnancy: costs and effectiveness in preventing perinatal transmission.
    Sansom SL; Jamieson DJ; Farnham PG; Bulterys M; Fowler MG
    Obstet Gynecol; 2003 Oct; 102(4):782-90. PubMed ID: 14551009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
    Avram CM; Greiner KS; Tilden E; Caughey AB
    Am J Obstet Gynecol; 2019 Sep; 221(3):265.e1-265.e9. PubMed ID: 31229430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should HIV testing for all pregnant women continue? Cost-effectiveness of universal antenatal testing compared to focused approaches across high to very low HIV prevalence settings.
    Ishikawa N; Dalal S; Johnson C; Hogan DR; Shimbo T; Shaffer N; Pendse RN; Lo YR; Ghidinelli MN; Baggaley R
    J Int AIDS Soc; 2016; 19(1):21212. PubMed ID: 27978939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of repeat HIV testing during pregnancy in a resource-limited setting.
    Kim LH; Cohan DL; Sparks TN; Pilliod RA; Arinaitwe E; Caughey AB
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):195-200. PubMed ID: 23392461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM; Tsevat J
    Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
    Immergluck LC; Cull WL; Schwartz A; Elstein AS
    Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of HIV rescreening during late pregnancy to prevent mother-to-child HIV transmission in South Africa and other resource-limited settings.
    Soorapanth S; Sansom S; Bulterys M; Besser M; Theron G; Fowler MG
    J Acquir Immune Defic Syndr; 2006 Jun; 42(2):213-21. PubMed ID: 16639346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and pilot testing of HIV screening program integration within public/primary health centers providing antenatal care services in Maharashtra, India.
    Bindoria SV; Devkar R; Gupta I; Ranebennur V; Saggurti N; Ramesh S; Deshmukh D; Gaikwad S
    BMC Res Notes; 2014 Mar; 7():177. PubMed ID: 24670002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Missed Opportunities for Repeat HIV Testing in Pregnancy: Implications for Elimination of Mother-to-Child Transmission in the United States.
    Liao C; Golden WC; Anderson JR; Coleman JS
    AIDS Patient Care STDS; 2017 Jan; 31(1):20-26. PubMed ID: 27936863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of HIV and syphilis antenatal screening: a modelling study.
    Bristow CC; Larson E; Anderson LJ; Klausner JD
    Sex Transm Infect; 2016 Aug; 92(5):340-6. PubMed ID: 26920867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of repeat HIV testing during pregnancy in southwestern Kenya: progress and missed opportunities.
    Rogers AJ; Akama E; Weke E; Blackburn J; Owino G; Bukusi EA; Oyaro P; Kwena ZA; Cohen CR; Turan JM
    J Int AIDS Soc; 2017 Dec; 20(4):. PubMed ID: 29236362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost effectiveness of voluntary prenatal and routine newborn HIV screening in the United States.
    Zaric GS; Bayoumi AM; Brandeau ML; Owens DK
    J Acquir Immune Defic Syndr; 2000 Dec; 25(5):403-16. PubMed ID: 11141240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants.
    Udeh B; Udeh C; Graves N
    BMC Infect Dis; 2008 Dec; 8():174. PubMed ID: 19117527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV testing among pregnant women with prenatal care in the United States: An analysis of the 2011-2017 National Survey of Family Growth.
    Olakunde BO; Pharr JR; Adeyinka DA
    Int J STD AIDS; 2020 Jun; 31(7):680-688. PubMed ID: 32538331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV testing among pregnant women living with HIV in India: are private healthcare providers routinely violating women's human rights?
    Madhivanan P; Krupp K; Kulkarni V; Kulkarni S; Vaidya N; Shaheen R; Philpott S; Fisher C
    BMC Int Health Hum Rights; 2014 Mar; 14():7. PubMed ID: 24656059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparison of three screening strategies for prevention of perinatal HIV infection in Colombia: a decision analysis model].
    Gómez M
    Rev Panam Salud Publica; 2008 Oct; 24(4):256-64. PubMed ID: 19133174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High uptake of HIV testing in pregnant women in Ontario, Canada.
    Remis RS; Merid MF; Palmer RW; Whittingham E; King SM; Danson NS; Vernich L; Swantee C; Major C
    PLoS One; 2012; 7(11):e48077. PubMed ID: 23152762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.